Artivion to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Artivion Inc. (NYSE: AORT), a leading cardiac and vascular surgery company, has announced its participation in two upcoming investor conferences. The company will present at the Canaccord Genuity 44th Annual Growth Conference on August 14, 2024, at 2:00 p.m. ET in Boston. A live webcast of the presentation will be available on Artivion's website and archived for 90 days.

Additionally, Artivion's management team will participate in investor meetings at the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 12-13, 2024. No webcast will be available for this virtual event due to its format. These conferences provide Artivion an opportunity to showcase its focus on aortic disease and engage with investors.

ATLANTA, Aug. 5, 2024 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it will participate in two upcoming investor conferences.

Artivion's management team will present at the upcoming Canaccord Genuity 44^th Annual Growth Conference on Wednesday, August 14, 2024 at the InterContinental Boston Hotel. The Company's presentation is scheduled to begin at 2:00p.m. ET. A live webcast can be accessed through Artivion's website, www.artivion.com, on the Investors page.  An archived copy of the webcast will be available for 90 days on the same website. 

Artivion management will also be participating in investor meetings at the 9^th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Monday and Tuesday, August 12-13, 2024. Due to the format of this event no webcast will be available.

About Artivion, Inc.

Headquartered in suburban Atlanta, Georgia, Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.Artivion.com.

Contacts:

Artivion Lance A. Berry Executive Vice President & Chief Financial Officer Phone: 770-419-3355

Gilmartin Group LLC Brian Johnston / Laine Morgan Phone: 332-895-3222 investors@artivion.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/artivion-to-participate-in-upcoming-investor-conferences-302214723.html

SOURCE Artivion, Inc.

FAQ

When is Artivion (AORT) presenting at the Canaccord Genuity Growth Conference in 2024?

Artivion (AORT) is scheduled to present at the Canaccord Genuity 44th Annual Growth Conference on Wednesday, August 14, 2024, at 2:00 p.m. ET.

Where can investors access the webcast of Artivion's (AORT) presentation at the Canaccord conference?

Investors can access the live webcast of Artivion's (AORT) presentation through the company's website, www.artivion.com, on the Investors page. An archived copy will be available for 90 days.

Which virtual conference is Artivion (AORT) participating in during August 2024?

Artivion (AORT) is participating in the 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 12-13, 2024.

Will there be a webcast available for Artivion's (AORT) participation in the Needham Virtual Conference?

No, there will not be a webcast available for Artivion's (AORT) participation in the Needham Virtual MedTech & Diagnostics 1x1 Conference due to the format of the event.